Paul T Quinlan - Net Worth and Insider Trading
Paul T Quinlan Net Worth
The estimated net worth of Paul T Quinlan is at least $0 dollars as of 2024-12-01. Paul T Quinlan is the General Counsel of CymaBay Therapeutics Inc and owns about 0 shares of CymaBay Therapeutics Inc (CBAY) stock worth over $0. Details can be seen in Paul T Quinlan's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Paul T Quinlan has not made any transactions after 2024-01-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Paul T Quinlan
Paul T Quinlan Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Paul T Quinlan owns 2 companies in total, including CymaBay Therapeutics Inc (CBAY) , and TerraVia Holdings Inc (TVIAQ) .
Click here to see the complete history of Paul T Quinlan’s form 4 insider trades.
Insider Ownership Summary of Paul T Quinlan
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CBAY | CymaBay Therapeutics Inc | 2024-01-16 | General Counsel |
| TVIAQ | TerraVia Holdings Inc | 2017-03-09 | General Counsel |
Paul T Quinlan Latest Holdings Summary
Paul T Quinlan currently owns a total of 1 stock. Paul T Quinlan owns 0 shares of CymaBay Therapeutics Inc (CBAY) as of January 16, 2024, with a value of $0.
Latest Holdings of Paul T Quinlan
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CBAY | CymaBay Therapeutics Inc | 2024-01-16 | 0 | 32.48 | 0 |
Holding Weightings of Paul T Quinlan
Paul T Quinlan Form 4 Trading Tracker
According to the SEC Form 4 filings, Paul T Quinlan has made a total of 9 transactions in CymaBay Therapeutics Inc (CBAY) over the past 5 years, including 0 buys and 9 sells. The most-recent trade in CymaBay Therapeutics Inc is the sale of 5,000 shares on January 16, 2024, which brought Paul T Quinlan around $117,900.
Insider Trading History of Paul T Quinlan
- 1
Paul T Quinlan Trading Performance
Paul T Quinlan Ownership Network
Paul T Quinlan Owned Company Details
What does CymaBay Therapeutics Inc do?
Who are the key executives at CymaBay Therapeutics Inc?
Paul T Quinlan is the General Counsel of CymaBay Therapeutics Inc. Other key executives at CymaBay Therapeutics Inc include Chief Scientific Officer Charles Mcwherter , Vice President & Finance Daniel Menold , and director & Chief Executive Officer Sujal Shah .
CymaBay Therapeutics Inc (CBAY) Insider Trades Summary
Over the past 18 months, Paul T Quinlan made 8 insider transaction in CymaBay Therapeutics Inc (CBAY) with a net sale of 88,000. Other recent insider transactions involving CymaBay Therapeutics Inc (CBAY) include a net sale of 149,810 shares made by Charles Mcwherter , a net sale of 52,442 shares made by Daniel Menold , and a net sale of 19,000 shares made by Janet Dorling .
In summary, during the past 3 months, insiders sold 0 shares of CymaBay Therapeutics Inc (CBAY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 454,897 shares of CymaBay Therapeutics Inc (CBAY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 454,897 shares.
CymaBay Therapeutics Inc (CBAY)'s detailed insider trading history can be found in Insider Trading Tracker table.
CymaBay Therapeutics Inc Insider Transactions
Paul T Quinlan Mailing Address
Above is the net worth, insider trading, and ownership report for Paul T Quinlan. You might contact Paul T Quinlan via mailing address: C/o Cymabay Therapeutics, Inc., 7575 Gateway Blvd., Suite 110, Newark Ca 94560.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
